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n@yahoAbstract Castleman disease is a lymphoproliferative disorder with unknown cause and a charac-
teristic hypervascular lymphoid hyperplasia. Commonly the disease is located in the mediastinum.
Head and neck is the second most common localization for the disease. However involvement of
parotid gland is extremely rare. We present a 29 year old female patient with parotid gland Castle-
man’s disease. Although it is rarely seen in the parotid gland, it should be considered in the differ-
ential diagnosis of cases with mass in the parotid gland.
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Castleman’s disease (CD) is a lymph node hyperplasia which
was ﬁrst described by Benjamin Castleman in 1956.1 It was
known by different names including lymphoid hamartoma,
giant lymph node hyperplasia, angiofollicular lymph nodeEar, Nose, Throat and Allied
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o.com (A.N. Erkan).hyperplasia, angiofollicular hamartoma and benign giant
lymphoma.1 Commonly the disease is located in the mediasti-
num.2 However, it may also be seen in other areas of the body,
where lymph nodes are normally found.2 Although the head
and neck area accounts for 14% of cases, nearly 90% of these
are located in the neck and the involvement of parotid gland is
extremely rare.3,4 This article presents a patient who was found
to have CD in the parotid region. Additionally, review of the
literature on this entity is discussed.
2. Case report
A 29-year-old female presented with a painless mass with 2-year
history, in the right neck region. She had no additional
symptoms, including fever, fatigue, weight loss and night
sweating. The mass was stationary in course. She had no other
comorbid disease. Rest of the history was unremarkable.
Physical examination revealed a solid, well marginating mass
in the right parotid region. Facial weakness was not observed.
General examination revealed no other swellings elsewhere.
Laboratory tests including blood glucose, kidney function tests,
Figure 1 Magnetic resonance imaging showed a 30 · 18 mm in
size, well marginated mass in the parotid region.
Figure 2 Lymphoid follicles with multiple germinal centers
(arrows: multiple germinal centers (HE 40·).
70 A.N. Erkan et al.liver function tests, cell blood count were in normal limits.
Chest X-ray was normal. Magnetic resonance imaging showed
a 30 · 18 mm in size, well marginated mass in the parotid
region (Fig. 1). Fine needle aspiration biopsy revealed polymor-
phic lymphoid population. No deﬁnitive diagnosis could be
achieved. Patient underwent a superﬁcial parotidectomy
operation. Histolopathological examination of the specimen
was reported as ‘Castleman disease, hyaline vascular type’
(Fig. 2). After 3 months follow-up the patient remains free of
disease.
3. Discussion
Castleman disease is a lymphoproliferative disorder with an
unknown cause and a characteristic hypervascular lymphoidhyperplasia, that was ﬁrst described by Benjamin Castleman
et al. in 1956.1,2 Although this disease has been reported at
all ages, it is very rare in children. The age at presentation
ranges from 2 months to 71 years. It is more commonly found
in young adults.2 It has no sex predilection. Our case was a 26-
year-old woman.
Castleman disease has been referred to by many names,
including giant lymph node hyperplasia, angiofollicular lymph
node hyperplasia, follicular lymphoreticuloma, and lymphoid
hamartoma.1–3 It has been commonly found in mediastinum
(60%), head and neck (14%), retroperitoneum (11%) or axilla
(4%). Nearly 90% of the head and neck cases, are located in
the neck and the involvement of parotid gland is extremely
rare with only 25 cases reported in the English language liter-
ature.1–4 Other localizations in the head and neck region are,
ﬂoor of the mouth, submandibular gland, larynx, palatal
region and parapharengeal space.3 In the head and neck
region, Castleman disease most commonly presents as a soli-
tary mass under the sternocleidomastoid muscle or arises as
an extension of a mediastinal mass. In our case, Castleman
disease was located within the parotid region. The majority
of the cases of Castleman disease of the parotid arise within
the para-glandular or intraglandular lymph nodes.2
Depending on the site, Castleman disease can be classiﬁed
into two groups: localized, unicentric or focal Castleman
disease and disseminated or multicentric Castleman disease.2
Localized CD presents as a slow growing mass and has a
benign prognosis.2 Multicentric CD manifests with diffuse
lympadenopathy within at least one regional group of lymp
nodes and has a poor prognosis.2 Castleman disease is divided
into three subtypes depending on histopathological examina-
tion. The ﬁrst type is hyaline-vascular type, which is character-
ized by concentrically arranged small lymphocytes (onion
skinning) around the numerous small, follicle-like structurewith
prominent vascular proliferation andhyalinization ismore com-
mon in young adults and older children. It is usually found in a
localized formwithout constitutional symptoms and has a more
favorable progress than the other subtypes. Histopathological
examination of our case was consistent with this type.2,3
The plasma cell type is characterized by sheets of mature
plasma cells in the interfollicular spaces and larger hyperplastic
follicles with less vascular proliferation.2 Twenty-two percent
of the localized and majority of the multicentric Castleman dis-
ease is plasma cell type. It is more frequently associated with
constitutional symptoms such as fever, fatigue, weight loss
and increase of erythrocyte sedimentation rate, thrombocyto-
sis, anemia, hypoalbuminemia and polyclonal hyperglobuline-
mia.1,2 These are more common in children.2 Systemic
chemotherapy including cyclophosphamide, vincristine sulfate,
doxorubicin and glucocorticoids may be required in this type
of Castleman disease. Radiotherapy is an alternative in cases
of unresectable lesions, incomplete excision, recurrence, and
poor surgical candidacy.2,3 The mixed type is rare and is histo-
logically a mixture of two other types, and symptom of this
type is associated with cell component.
The origin of this entity is still unknown. Some authors
favor a theory of lympho-proliferation due to chronic anti-
genic stimulation by a virus or chronic inﬂammation while oth-
ers consider it to be a lymphoid hamartoma.5
Clinically Castleman disease is not common and the diagno-
sis is challenging due to its rarrity and the absence of speciﬁc
signs.1–5 Most patients presented with slowly enlarging
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gion without any obvious symptoms as seen in our case. The
clinical manifestations of this disease, are not speciﬁc and are
always similar to the benign lesions of the parotid and neck re-
gion. The unicentric lesion in the parotid gland is difﬁcult to
differentiate from Warthin tumor, pleomorphic adenoma,
schwannoma.1 Multicentric disease, may be associated with
polyneuropathy, organomegaly, endocrinopathy, anemia.3
Imaging examination can be useful for the diagnosis and
the differential diagnosis.1 Ultrasonography is efﬁcient to
evaluate the hypervascular nature of the disease. Computed
tomography scan with contrast shows a densely enhancing,
well-circumscribed, homogenous mass which reﬂects the
hypervascularity of these lesions. However, to date no radio-
logical study is diagnostic.2 Magnetic resonance imaging can
give a useful information, such as rich vascular bundles from
local blood vessels, because the masses of Castleman disease
are always observed with a rich blood supply during the surgi-
cal operation.1 The mass showed low signal in T1 weighted
sections and in T2 weighted sections it was with high signal
intensity.4
The treatment of choice for this disease is surgical excision.
The excision is both diagnostic and therapeutic.5 Recurrencesare rare in the hyaline vascular type; however, follow-up is re-
quired in plasma cell type lesion.
In conclusion, Castleman disease is a rare entity, especially
in the parotid region. Though it has a benign course, differen-
tial diagnosis from other head and neck masses may be chal-
lenging and awareness of the physician is required.
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